Research
Mays Cancer Center selected as founding partner of oncology clinical trial diversity alliance
June 23, 2021
The Mays Cancer Center, home to UT Health San Antonio MD Anderson, was named a founding partner of the Advancing Inclusive Research® Site Alliance.
LINC Seed Grant awards support pilot projects to foster innovations in interprofessional education
June 18, 2021
The annual Linking Interprofessional Networks for Collaboration (LINC) Seed Grant Program encourages faculty and staff to develop novel interprofessional education (IPE) activities and promotes IPE research and scholarship.
Depression, tau deposits seen in subset of middle-aged persons
June 17, 2021
Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new study by researchers from UT Health San Antonio and collaborating institutions suggests.
In JAMA Oncology: Convalescent plasma improves survival in COVID-19 patients with blood cancers
June 17, 2021
Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. The findings by the COVID-19 and Cancer Consortium (CCC19) are newly published in the peer-reviewed journal JAMA Oncology.
Novavax vaccine is highly protective against COVID-19 in Phase 3 results
June 17, 2021
UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.
Voelcker Fund supports cancer research and discovery at UT Health San Antonio
June 15, 2021
The Max and Minnie Tomerlin Voelcker Fund is awarding $800,000 to UT Health San Antonio to support research projects conducted by promising early career researchers.